Discover 921 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 921
Active & Responsive
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice
for
Cancer Metastatic
Location: Hillsboro OR
Sponsor: Care Partners
Sex: All
Age: 18 - 70+
Code: NCT04049188
Recruiting
Z1 Hip System: Post-Market Clinical Follow Up Study
for
Hip Osteoarthritis,
Location: Portland OR, Cleveland OH, Charlotte NC
Sponsor: Zimmer Biomet
Sex: All
Age: 18+
Code: NCT07104279
Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Portland OR, Eugene OR, Walnut Creek CA, Campbell CA,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase2, Recruiting
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
for
Diabetic Macular Edema
Location: Portland OR, Eugene OR, Sacramento CA, Walnut Creek CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07553429
Phase1, Phase2, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy